Skip to main content
. Author manuscript; available in PMC: 2024 May 8.
Published in final edited form as: Int J Drug Policy. 2021 Aug 3;97:103321. doi: 10.1016/j.drugpo.2021.103321

Table 2:

Multilevel mixed effects unadjusted (OR), adjusted (aOR), p-values, and 95% Confidence Intervals for the relationship between socio-ecological, pharmacy-level factors and stocking buprenorphine.

OR 95%CI p value aOR 95%CI p<.value
Socio-ecological factors
Race M(SD)
Non-Hispanic Black .80 (0.69, 0.93) .003 .89 (0.77, 1.03) .110
Hispanic .66 (0.50, 0.87) .003 .94 (0.72, 1.24) .688
Uninsured .30 (0.22, 0.37) <0.001 .23 (0.14, 0.38) <0.001
Pharmacy-level factors
Number of private spaces 2.03 (1.52, 2.72) <0.001 1.67 (1.20, 2.32) .002
Large pharmacy 2.45 (1.73, 3.45) <0.001 1.52 (1.04, 2.22) .032
Naloxone in stock 3.22 (2.10, 4.95) <0.001 1.54 (1.03, 2.32) .037
Model 2
Poverty M(SD) .49 (0.31, 0.76) <0.001 .93 (0.34, 2.51) .886

Model 2 adjusts for race/ethnicity and pharmacy-level factors of number of private spaces, chain pharmacy, naloxone in stock.